K-pop

Chu Parts Ways with ATRP… Putting an End to a Three-Year Partnership

Exclusive Contract Ends on the 10th "Cheering Each Other On for the Future"

YUN GI BACK
2026-07-10 13:58:02
[E-Daily Starin YUN GI BACK Reporter] Singer CHUU is parting ways with her agency, ATRP.
CHUU (Photo courtesy of ATRP)

ATRP announced in an official statement on the 10th, “The exclusive contract between our agency and our artist CHUU has ended as of July 10, 2026.”
The agency stated, “We held in-depth discussions regarding CHUU’s future activities and agreed to conclude the exclusive contract with the hope of supporting each other’s future endeavors.”
They continued, “We would like to thank all the fans who have shown Chuu unwavering love and support over the years,” adding, “We ask for your continued interest and encouragement.”
After signing an exclusive contract with ATRP in 2023, Chuu embarked on a new journey as a solo artist. Since then, she has established her own musical identity, starting with her first mini-album *Howl* and followed by releases such as *Strawberry Rush* and *Only Cry in the Rain*.
Chu, who has solidified her position as a solo artist not only through her music but also by actively participating in variety shows, commercials, and other content, will be seeking a new agency following the expiration of this contract.

Economy

Corporation

IT·Science

Economy

'Korea Expo' Makes Stops in Paris, Osaka, and Tokyo Before Landing in the U.S.

The "Korea Expo," a comprehensive consumer goods trade show, opened on the 22nd at Magic Box in downtown Los Angeles and will run through the 24th. This marks the first time the Korea Expo—which debut…
2026-10-24 06:54:22

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02